Working... Menu

Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors (SABR-COMET 10)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03721341
Recruitment Status : Recruiting
First Posted : October 26, 2018
Last Update Posted : February 26, 2019
Amsterdam University Medical Centre, VUmc Site
British Columbia Cancer - Centre for the North
Beaston West of Scotland Cancer Centre
London Health Sciences Centre
Information provided by (Responsible Party):
David Palma, Lawson Health Research Institute

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : January 2029
  Estimated Study Completion Date : January 2029